Despite obesity’s well-known influence on AF recurrence, neither comorbidity has a significant influence on outcomes from early… Read More
FDA grants Fast Track to NRX-100, the first preservative-free IV ketamine, for treating suicidal ideation in depression. Read More
After overcoming 2 FDA rejections, PharmaTher secures approval for ketamine (KETARX) in surgical pain. Read More
At the recent Association of Women in Rheumatology annual conference, AWIR and ACR leaders discussed advocacy’s important… Read More
On July 31, President Trump sent formal letters to the CEOs of 17 major pharmaceutical companies, laying… Read More
A 15% tariff on all European Union exports, including pharmaceuticals, went into effect on Aug. 7. The… Read More
Counting down the most impactful news at major medical meetings, it’s the HCPLive Five! This episode focuses… Read More
Panelists discuss how access challenges include insurance barriers and prior authorizations for medications, while identifying key gaps… Read More
The use of cell therapy in rheumatology is likely to expand considerably in the coming years, according… Read More
A July 30 memo from Attorney General Pam Bondi clarifies how federal anti-discrimination laws apply to programs… Read More